Home
Pharmerit

Pharmerit Market Share Analysis for November 2025

OPEN Health is a medical affairs partner providing HEOR, market access, medical communication and omni campaign consulting services.

Health > Biotechnology and Pharmaceuticals

Domainpharmerit.com

Year Founded2000

Employees51 - 200

Annual Revenue$15M - $25M

Pharmerit

Pharmerit (including company regionals)

pharmerit.com

See more website traffic and engagement information

Pharmerit Revenue up to November 2025 is 15M - 25M

revenue generated by Pharmerit top domains

Pharmerit top domains revenue over 3 years

Revenue for Pharmerit top domains

pharmerit.com15M - 25M

See more with Sales Intelligence

Total visits to Pharmerit's top domains

Understand Pharmerit market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pharmerit's top domains

Analyze Pharmerit engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pharmerit's top domains

See how Pharmerit keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pharmerit top competitors by domain

Top similar sites in November 2025, ranked by their affinity

rtihs.orgCompany NameRTI Health SolutionsEmployees201 - 500HQUnited States, California, Santa ClaraAnnual revenue$25M - $50MTotal visits35.6KHealth > Health - Other

Top technologies used by Pharmerit

These are the website technologies, by industry, used by Pharmerit top domains

Payment & Currencies (14)

Cart Functionality

Advertising (5)

DoubleClick

Social (5)

Instagram

eCommerce (4)

WooCommerce

More Technologies

11

See all

News & Signals from Pharmerit

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPharmerit International is developing discrete-choice experiment exploring caregivers’ benefit-risk tradeoffs for emerging PWS treatments.PharMerit BV partnered with PWS patient organizations to develop a discrete-choice experiment exploring caregivers’ benefit-risk tradeoffs for emerging PWS treatments.

NewsMallinckrodt partners with Pharmerit International.Mallinckrodt will partner with Pharmerit - an OPEN Health company - to collect data from approximately 200 hospitalized adult patients with a confirmed diagnosis of COVID-19 who were treated with INOmax for pulmonary complications associated with COVID-19 for at least 24 hours between January 1, 2020 and July 31, 2020.

NewsPharmerit International hires Jordana Schmier as Director within the Real-World Evidence Center of Excellence.Pharmerit is pleased to welcome Jordana Schmier, who will join Pharmerit as Director within the Real-World Evidence Center of Excellence.